CIK 0001108205
- Non-accelerated filer
- Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043505116
- Phone
- +1 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 185,000 shares (grant or award)
- 4 Grant or award Director acquired 185,000 shares (grant or award)
- 4 Grant or award Director acquired 185,000 shares (grant or award)
- 4 Grant or award Director acquired 185,000 shares (grant or award)
- 4 Grant or award Director acquired 185,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 133,750 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 206,250 shares (grant or award)
- 4 Grant or award President & CEO acquired 206,250 shares (grant or award)
- 4 Open-market buy Director bought 25,000 shares at $0.98 ($24,500)
- 4 Open-market buy President & CEO bought 50,000 shares at $1.06 ($53,000)
- 4 Shares withheld for taxes Director gave up 12,193 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 12,193 shares (to pay taxes)
- 4/A Open-market sale Director sold 76,276 shares at an average $2.04 ($155,424)
- 4 Open-market sale Director sold 76,276 shares at an average $2.04 ($155,424)
- 4 Open-market sale Director sold 116,708 shares at an average $2.38 ($278,037)
- 4/A Open-market sale Director sold 110,322 shares at an average $2.59 ($285,682)
- 4 Open-market sale Director sold 146,694 shares at an average $2.61 ($383,019)
Page 6 of 24 · 475 filings